% Expired Patents = 33.3

EPO Patents = 2

Forward Citations = 8

Loading Chart...

9 inventors (with patents filed for the assignee):

Richard M Thorn (5 out of 12 patents)

Chris Sterzinger (3 out of 3 patents)

Cara Ferreira (3 out of 3 patents)

4. David Leyh (3 out of 3 patents)

5. Mark R Hurtt (2 out of 2 patents)

6. Marsha A Moses (1 out of 22 patents)

7. Noel James Cusack (1 out of 1 patent)

8. Mark A Lanser (1 out of 1 patent)

9. Dmitri G Wiederschain (1 out of 8 patents)

10. Mark Hurtt (0 patent)

6 patents: Sort by Forward Citations

1. 9757483 - Labeled iodinated tropane formulation (2017-09-12),

2. 8986653 - Labeled iodinated tropane formulation (2015-03-24),

3. 8574545 - Labeled iodinated tropane formulation (2013-11-05),

4. 8133861 - Systemic purine administration: modulating axonal outgrowth of central nervous system neurons (2012-03-13),

5. 8084018 - Methods for imaging dopamine transporter level (2011-12-27),

6. 7452866 - Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1 (2008-11-18),

Company Overview

Alseres Pharmaceuticals, Inc. is a biotechnology company focused on developing therapeutic and diagnostic products for neurological disorders. The company's pipeline includes treatments for Parkinson's disease, traumatic brain injury, and other central nervous system conditions. Their innovative approach to drug development aims to address unmet medical needs and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#15 in Hopkinton, MA

#2,546 in Massachusetts

#45,007 in US

Hopkinton, MA, United States of America

Alseres Pharmaceuticals, Inc.

Forward Citations = 8

9 inventors:

Richard M Thorn (5 out of 12 patents)

Chris Sterzinger (3 out of 3 patents)

Cara Ferreira (3 out of 3 patents)

4. David Leyh (3 out of 3 patents)

5. Mark R Hurtt (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alseres Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/alseres-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]